Indica Labs Sets New Standard for Molecular Testing in Breast Cancer with Expansion of AI Macrodissection Portfolio
recent articles
Exeter, England, April 19th 2023 — Diagnexia UK Limited, owned by Deciphex, is the UK's fastest-growing pathology diagnostics service provider. Today, the company proudly celebrated the launch of its expanded facility at Exeter Science Park....
PathAI and ConcertAI: Researchers derive novel insights through the combination of PathAI's proprietary tumor microenvironment features with ConcertAI's multi-modal clinical data BOSTON, April 25, 2023 /PRNewswire/ -- PathAI, a global...
Indica Labs and Lunit: Enabling clinical effectiveness via a fully interoperable and integrated digital pathology solution. ALBUQUERQUE, N.M. and SEOUL, South Korea, April 25, 2023 /PRNewswire/ -- Indica Labs, an industry leader in...
HAMBURG, Germany--(BUSINESS WIRE)--In a first of its kind comparative study, Mindpeak's CE-marked HER2 AI for breast cancer diagnosis was compared to three other commercial AIs (e.g. Visiopharm). Mindpeak's AI showed the highest accuracy of...
Proscia: Cloud-based digital pathology platform helps CRO deliver more informed preclinical studies NEW HAVEN, CONN. and PHILADELPHIA – April 24, 2023 – Proscia®, a leading provider of digital and computational pathology solutions,...
Gestalt Diagnostics: PAIP 2023 Challenge Winner and MICCAI 2022 ACROBAT Challenge Winner SPOKANE, Wash., April 21, 2023 /PRNewswire/ -- Gestalt Diagnostics is honored to have taken 1st place in both International challenges. Hundreds of...
